Glaxosmithkline | Salgsomkostninger Og Administration

Selling And Administration Expenses Lave om Dato
Amgen USD 1.76B 424M 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Aurora Cannabis CAD 43.79M 774K 2023-03
Bausch Health Companies USD 715M 4M 2023-09
Canopy Growth CAD 60.33M 26.29M 2023-09
Catalent USD 250M 45M 2023-12
Corcept Therapeutics USD 47.15M 1.89M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Pacira USD 65.8M 2.15M 2023-12
Perrigo USD 304M 28.3M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Prestige Brands USD 65.47M 630K 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Supernus Pharmaceuticals USD 81.28M 1.42M 2023-12
Takeda JPY 252.95B 4.84B 2023-09
Teva Pharmaceutical Industries USD 844M 66M 2023-09
Zoetis USD 565M 40M 2023-12



Glaxosmithkline Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.